Clinical Pharmacokinetic Study of Lurbinectedin in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Impairment

Clinical trial NCT05101265 · UNKNOWN

Trial details

NCT number: NCT05101265
Sponsor: PharmaMar
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor Hepatic Impairment

Start date: 2021-03-09
Primary completion: 2025-06-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.